Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
// Radka Stoyanova 1 , Alan Pollack 1 , Mandeep Takhar 2 , Charles Lynne 3 , Nestor Parra 1 , Lucia L.C. Lam 2 , Mohammed Alshalalfa 2 , Christine Buerki 2 , Rosa Castillo 4 , Merce Jorda 3, 5 , Hussam Al-deen Ashab 2 , Oleksandr N. Kryvenko 3, 5 , Sanoj Punnen 3 , Dipen J. Parekh 3 , Matthew C. Abramowitz 1 , Robert J. Gillies 6 , Elai Davicioni 2 , Nicholas Erho 2 , Adrian Ishkanian 1 1 Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA 2 Reserach and Development, GenomeDx Biosciences, Vancouver, BC, Canada 3 Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA 4 Department of Radiology, University of Miami Miller School of Medicine, Miami, FL, USA 5 Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA 6 Cancer Imaging and Metabolism, Moffitt Cancer Center, Tampa, FL, USA Correspondence to: Radka Stoyanova, email: rstoyanova@med.miami.edu Keywords: prostate cancer, multiparametric MRI, MRI-targeted biopsies, gene expression, radiogenomics Received: February 26, 2016 Accepted: June 30, 2016 Published: July 11, 2016 ABSTRACT Standard clinicopathological variables are inadequate for optimal management of prostate cancer patients. While genomic classifiers have improved patient risk classification, the multifocality and heterogeneity of prostate cancer can confound pre-treatment assessment. The objective was to investigate the association of multiparametric (mp)MRI quantitative features with prostate cancer risk gene expression profiles in mpMRI-guided biopsies tissues. Global gene expression profiles were generated from 17 mpMRI-directed diagnostic prostate biopsies using an Affimetrix platform. Spatially distinct imaging areas (‘habitats’) were identified on MRI/3D-Ultrasound fusion. Radiomic features were extracted from biopsy regions and normal appearing tissues. We correlated 49 radiomic features with three clinically available gene signatures associated with adverse outcome. The signatures contain genes that are over-expressed in aggressive prostate cancers and genes that are under-expressed in aggressive prostate cancers. There were significant correlations between these genes and quantitative imaging features, indicating the presence of prostate cancer prognostic signal in the radiomic features. Strong associations were also found between the radiomic features and significantly expressed genes. Gene ontology analysis identified specific radiomic features associated with immune/inflammatory response, metabolism, cell and biological adhesion. To our knowledge, this is the first study to correlate radiogenomic parameters with prostate cancer in men with MRI-guided biopsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132 · cited 2×
“We linked radiomic features to existing genomic and clinical information to improve risk stratification, as has been previously described by us [10] and others for different tumor types [11].”
MethodSelf-citationQuantitative Imaging in Cancer Evolution and Ecology
Gatenby, R. A., Grove, O., & Gillies, R. J. (2013) · Radiology · doi:10.1148/radiol.13122697 · Cited by 515
Self-citationZhou, M., Hall, L., Goldgof, D., Russo, R., Balagurunathan, Y., Gillies, R., & Gatenby, R. (2014) · Translational Oncology · doi:10.1593/tlo.13730 · Cited by 97 · cited 1×
“While advances have been made in structuring the assessment and biopsy of abnormalities in the prostate using mpMRI via PI-RADS [20], there remains considerable subjectivity and no incorporation of quantitative information.”
BackgroundSelf-citation
Cited by
Radiogenomics: bridging imaging and genomics
Bodalal, Z., Trebeschi, S., Nguyen-Kim, T. D. L., Schats, W., & Beets-Tan, R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02028-w · Cited by 310
Radiomics Improves Cancer Screening and Early Detection
Gillies, R. J., & Schabath, M. B. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0075 · Cited by 159
Self-citationJansen, R. W., van Amstel, P., Martens, R. M., Kooi, I. E., Wesseling, P., de Langen, A. J., Menke-Van der Houven van Oordt, C. W., Jansen, B. H. E., Moll, A. C., Dorsman, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24893 · Cited by 63
Metadata
- Authors
- Stoyanova, R., Pollack, A., Takhar, M., Lynne, C., Parra, N., Lam, L. L. C., Alshalalfa, M., Buerki, C., Castillo, R., Jorda, M., Ashab, H. A.-D., Kryvenko, O. N., Punnen, S., Parekh, D. J., Abramowitz, M. C., Gillies, R. J., Davicioni, E., Erho, N., & Ishkanian, A.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-07-11
- Volume
- 7
- Issue
- 33
- Pages
- 53362-53376
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2467451464
- Cited by
- 106
- References
- 4
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.